Date of Conferral
8-28-2025
Degree
Doctor of Business Administration (D.B.A.)
School
Business Administration
Advisor
Betsy Macht
Abstract
Poor management of pharmaceutical project portfolios can negatively impact a pharmaceutical company’s product development and profitability. Project portfolio managers must ensure the successful development of new products in the pharmaceutical pipeline as the financial investment in new product development is significant and if not managed effectively can negatively impact profitability and prevent launch of new treatment therapies. Grounded in the project portfolio management framework, the purpose of this qualitative pragmatic inquiry study was to explore successful project portfolio management (PPM) strategies that drug project portfolio managers use to contribute to business success. The participants were six employees that managed portfolios within the top 50 pharmaceutical companies. Data were collected using semistructured interviews. Through thematic analysis, six themes were identified: (a) justification for and use of software tools, (b) identification of key performance indicators (KPI), (c) alignment of business goals across the organization, (d) risk management strategies, (e) leadership behaviors, and (f) budget management. The implications for social change include the potential for leaders in the pharmaceutical industry and health care leaders to advance healthcare by improving the chances of bringing safe and effective therapies to the market quicker, thereby providing the public access to treatments.
Recommended Citation
Nguyen, Emely Nhi Thi Ai, "Strategies to Improve Project Portfolio Management in the Pharmaceutical Industry" (2025). Walden Dissertations and Doctoral Studies. 18348.
https://scholarworks.waldenu.edu/dissertations/18348
